TLRY vs VANI · rev $915.5M vs $99.2M cap
Tilray Inc (TLRY) versus Vivani Medical Inc. (VANI) — a side-by-side from cached financials, not a winner call.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Vivani Medical Inc. (VANI) is a biotechnology company listed on NASDAQ.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
Latest reported VANI revenue for 2025-06-30 was $0. Net income was -$13.4M. VANI currently screens at market cap $99.2M.
TLRY currently screens at market cap $573.9M. VANI currently screens at market cap $99.2M.
Not investment advice. Open the TLRY and VANI stock pages for the full models.
Not investment advice.